Assertio (NASDAQ:ASRT – Get Rating) had its price target increased by BWS Financial from $6.00 to $8.00 in a research note issued to investors on Friday, The Fly reports. They currently have a buy rating on the stock.
A number of other equities research analysts have also recently weighed in on ASRT. StockNews.com raised Assertio from a hold rating to a buy rating in a report on Wednesday, November 9th. Lake Street Capital initiated coverage on Assertio in a report on Monday, November 7th. They set a buy rating and a $7.00 price target on the stock. Four analysts have rated the stock with a buy rating, According to data from MarketBeat.com, the stock currently has an average rating of Buy and a consensus target price of $7.50.
Assertio Stock Performance
Shares of ASRT stock opened at $6.21 on Friday. The business has a 50 day moving average of $4.50 and a two-hundred day moving average of $3.37. The company has a market cap of $299.88 million, a P/E ratio of 11.50, a PEG ratio of 1.24 and a beta of 1.38. The company has a quick ratio of 1.22, a current ratio of 1.37 and a debt-to-equity ratio of 0.49. Assertio has a 52 week low of $1.86 and a 52 week high of $6.34.
Institutional Investors Weigh In On Assertio
Assertio Holdings, Inc engages in the provision of commercial pharmaceutical products. Its commercial portfolio of branded products focuses on the following areas: neurology, hospital, and pain and inflammation. The company was founded on August 7, 1995 and is headquartered in Lake Forest, IL.
- Get a free copy of the StockNews.com research report on Assertio (ASRT)
- MarketBeat Week in Review – 2/27 – 3/3
- The 3 Most Upgraded Stocks Are Reversing
- How to Find Blue Chip Dividend Stocks
- Zscaler, Inc Plummets, Is It Time To Buy The Dip?
- What is a Good Dividend Yield? How to Decide
Receive News & Ratings for Assertio Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Assertio and related companies with MarketBeat.com's FREE daily email newsletter.